LAM RESEARCH CORP
Business
LAM RESEARCH CORP is a global supplier of wafer fabrication equipment and services for the semiconductor industry. It offers deposition, etch, and clean systems, advanced packaging and wafer-level packaging solutions, electrochemical and chemical vapor deposition, ALD, PECVD, HDP-CVD, reactive ion etch, wet and plasma cleans, and lifecycle services such as spares, upgrades, and Equipment Intelligence®. Key business areas include its product families for deposition, etch and clean and the Customer Support Business Group (CSBG). The company sells and services equipment worldwide across Asia, Europe, and the United States through a direct sales force and global service network to memory, foundry, and integrated device manufacturers.
Summary from filing dated 2025-08-11
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Revenue | 18,436 | 14,905 | 17,429 | 17,227 | 14,626 | |
| Cost of goods sold | 9,457 | 7,809 | 9,573 | 9,355 | 7,821 | |
| Restructuring charges, net - cost of goods sold | 0 | 43 | 78 | 0 | 0 | |
| Total cost of goods sold | 9,457 | 7,853 | 9,652 | 9,355 | 7,821 | |
| Gross margin | 8,979 | 7,053 | 7,777 | 7,872 | 6,805 | |
| Research and development | 2,096 | 1,902 | 1,727 | 1,604 | 1,493 | |
| Selling, general, and administrative | 982 | 868 | 833 | 886 | 830 | |
| Restructuring charges, net - operating expenses | 0 | 18 | 42 | 0 | 0 | |
| Total operating expenses | 3,078 | 2,789 | 2,602 | 2,490 | 2,323 | |
| Operating income | 5,901 | 4,264 | 5,175 | 5,382 | 4,482 | |
| Other income (expense), net | 57 | 96 | −66 | −189 | −111 | |
| Income before income taxes | 5,958 | 4,360 | 5,109 | 5,193 | 4,371 | |
| Income tax expense | −600 | −532 | −598 | −588 | −462 | |
| Net income | 5,358 | 3,828 | 4,511 | 4,605 | 3,908 | |
| Basic (usd per share) | 4.17 | 2.91 | 3.33 | 32.92 | 27.22 | |
| Diluted (usd per share) | 4.15 | 2.9 | 3.32 | 32.75 | 26.9 | |
| Basic (in shares) | 1,286 | 1,314 | 1,355 | 140 | 144 | |
| Diluted (in shares) | 1,290 | 1,320 | 1,358 | 141 | 145 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 6,391 | 5,848 | 5,337 | 3,522 | 4,418 | |
| Accounts receivable, less allowance of $6,496 as of June 29, 2025 and $5,277 as of June 30, 2024 | 3,378 | 2,519 | 2,823 | 4,314 | 3,026 | |
| Inventories | 4,308 | 4,218 | 4,816 | 3,966 | 2,689 | |
| Prepaid expenses and other current assets | 440 | 298 | 252 | 347 | 208 | |
| Total current assets | 14,517 | 12,883 | 13,228 | 12,285 | 11,652 | |
| Property and equipment, net | 2,429 | 2,155 | 1,857 | 1,648 | 1,303 | |
| Goodwill and intangible assets, net | 1,809 | 1,765 | — | — | — | |
| Other assets | 2,591 | 1,942 | 1,906 | 1,394 | 1,061 | |
| Total assets | 21,345 | 18,745 | 18,782 | 17,196 | 15,892 | |
| Trade accounts payable | 854 | 614 | 471 | 1,011 | 830 | |
| Accrued expenses and other current liabilities | 2,394 | 1,802 | 2,011 | 1,974 | 1,719 | |
| Deferred profit | 2,566 | 1,418 | 1,695 | 1,572 | 967 | |
| Current portion of long-term debt and finance lease obligations | 754 | 505 | 8 | 7 | 11 | |
| Total current liabilities | 6,568 | 4,338 | 4,185 | 4,565 | 3,528 | |
| Long-term debt and finance lease obligations | 3,730 | 4,479 | 5,003 | 4,998 | 4,990 | |
| Income taxes payable | 603 | 813 | 882 | 931 | 948 | |
| Other long-term liabilities | 582 | 575 | 501 | 423 | 399 | |
| Total liabilities | 11,484 | 10,205 | 10,571 | 10,917 | 9,865 | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock, at par value of $0.001 per share; authorized 4,000,000 shares as of June 29, 2025 and June 30, 2024; issued and outstanding 1,268,740 shares as of June 29, 2025, and 1,303,769 shares as of June 30, 2024 | 1 | 1 | 133,000 | 137,000 | 143,000 | |
| Additional paid-in capital | 8,697 | 8,223 | 7,809 | 7,415 | 7,053 | |
| Treasury stock, at cost, 1,687,582 shares as of June 29, 2025, and 1,648,239 shares as of June 30, 2024 | −27,763 | −24,366 | −21,530 | −19,481 | — | |
| Accumulated other comprehensive loss | −62 | −130 | −101 | −110 | −64 | |
| Retained earnings | 28,989 | 24,811 | 22,032 | 18,455 | 14,685 | |
| Total stockholders equity | 9,862 | 8,539 | 8,210 | 6,278 | 6,027 | |
| Total liabilities and stockholders equity | 21,345 | 18,745 | 18,782 | 17,196 | 15,892 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 386 | 360 | 342 | 334 | 307 | |
| Deferred income taxes | −363 | −199 | −172 | −257 | −151 | |
| Equity-based compensation expense | 343 | 293 | 287 | 259 | 220 | |
| Other, net | 7 | 10 | 52 | −45 | −17 | |
| Accounts receivable, net of allowance | −859 | 303 | 1,452 | −1,288 | −929 | |
| Inventories | −181 | 529 | −962 | −1,351 | −793 | |
| Prepaid expenses and other assets | −207 | −16 | 136 | −53 | −59 | |
| Trade accounts payable | 212 | 126 | −522 | 168 | 185 | |
| Deferred profit | 1,148 | −277 | 163 | 605 | 508 | |
| Accrued expenses and other liabilities | 328 | −305 | −109 | 123 | 409 | |
| Net cash provided by operating activities | 6,173 | 4,652 | 5,179 | 3,100 | 3,588 | |
| Capital expenditures and intangible assets | −759 | −397 | −502 | −546 | −349 | |
| Business acquisitions, net of cash acquired | 0 | 0 | −120 | 0 | 0 | |
| Proceeds from maturities of available-for-sale securities | 0 | 34 | 91 | 190 | 2,382 | |
| Proceeds from sales of available-for-sale securities | 0 | 3 | 7 | 1,543 | 1,472 | |
| Other, net | 51 | −12 | −11 | −8 | −42 | |
| Net cash used for investing activities | −708 | −371 | −535 | 612 | 73 | |
| Principal payments on long-term debt and finance lease obligations and payments for debt issuance costs | −507 | −256 | −23 | −12 | −862 | |
| Treasury stock purchases | −3,422 | −2,843 | −2,017 | −3,866 | −2,698 | |
| Dividends paid | −1,150 | −1,019 | −908 | −815 | −727 | |
| Reissuances of treasury stock related to employee stock purchase plan | 140 | 120 | 110 | 108 | 98 | |
| Proceeds from issuance of common stock | 2 | 16 | 11 | 6 | 24 | |
| Other, net | 143,000 | −14 | −4 | 45,000 | −2 | |
| Net cash used for financing activities | −4,937 | −3,996 | −2,831 | −4,579 | −4,167 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 28 | −22 | 128,000 | −30 | 7 | |
| Net change in cash, cash equivalents and restricted cash | 557 | 263 | 1,814 | −897 | −498 | |
| Accrued payables for stock repurchases, including applicable excise tax | 39 | 51 | 45 | 46,000 | 20 | |
| Accrued payables for capital expenditures | 81 | 61 | 32 | 80 | 61 | |
| Transfers of finished goods inventory to property and equipment | 91 | 71 | 77 | 75 | 80 | |
| Cash payments for interest | 172 | 173 | 175 | 176 | 204 | |
| Cash payments for income taxes, net | 973 | 992 | 810 | 808 | 519 |